Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade N/A
- Symbol (EMBCV)
- Company Embecta Corp.
- Price $33.33
- Changes Percentage (-9.33%)
- Change -$3.43
- Day Low $33.33
- Day High $38.21
- Year High $49.00
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $36.00
- High Stock Price Target $36.00
- Low Stock Price Target $36.00
- Potential Upside/Downside N/A
- Consensus Rating N/A
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $70.40 M
Income Statement
Quarterly
Annual
Latest News of EMBCV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching
Embecta Corp. (NASDAQ:EMBC) has shown promising growth potential despite not reaching its peak. Analyzing its valuation, the stock appears undervalued compared to industry peers, making it a potential...
By Yahoo! Finance | 5 months ago
